The Association for the Advancement of Medical Instrumentation (AAMI) and the British Standards Institute (BSI) published a guidance document on 31 May on risk management for artificial intelligence and machine learning devices. The document has already been recognized as meeting the requirements for medical devices laid out in the US Food, Drug and Cosmetics Act.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?